As co-chairs of the Barrier Track program at the 2018 ISPE Aseptic Conference, Michael Faia and I built this year’s program around real-world case studies from an all-star line-up of leading sterile manufacturers including:
This optimized case study format tells eight stories of major, real-world sterile projects by actual owners. These narrative-style presentations explain project goals, time lines, problems and challenges, and how issues were overcome. We have maximized the engineering focus in 2018, covering technical issues, problem solving, risk analysis, and lessons learned using numerous pictures, layouts, diagrams, and data.
Highlights of the Barrier Track at the 2018 ISPE Aseptic Conference include sessions focused on:
The 2018 ISPE Aseptic Conference, 6 -7 March in Reston, VA, marks 27 years of providing critical information about engineering solutions and how to provide cost effective facilities which make best use of available modern technology to ensure that products of the highest quality are consistently and reliably manufactured. The conference educates pharmaceutical manufacturing professionals, especially engineers.
In two packed days, you will get a panoramic view of what is trending around the world and how leading companies in sterile manufacturing are bringing innovation and advanced aseptic technology on-line. The 2018 ISPE Aseptic Conference will have a topic of interest for everyone!
I invite you as fellow engineers to check-out this optimized case-study format for the Barrier Track at 2018 ISPE Aseptic Conference. Stay tuned over the next several weeks, as we continue to share more reasons on why the 2018 ISPE Aseptic Conference is the must-attend conference for aseptic processing. We look forward to seeing you there.
In the pharmaceutical industry, which is highly regulated, aseptic processing is a critical component that ensures the sterility of products. Regulators have a set of comprehensive requirements that minimize the risk of contamination. Regulators set the requirements; however, the industry has an obligation to the patients who rely on and expect a drug that is safe and free of contamination....
Like any investment in digital manufacturing systems, demonstrating business payback before and after investment is critical to getting MES projects approved and verifying profitability after investment. Whether it is introducing MES, expanding it to additional sites, switching software, upgrading existing software, or developing electronic production records (EPR) for new drug products,...
Sustainability is emerging as a pivotal force influencing the pharmaceutical industry’s dynamics and steering companies towards transformative change. The focus of this analysis is to delve into the sustainability key performance indicators (KPIs) of prominent pharmaceutical players, namely Pfizer, Sanofi, Glaxo Smith Kline (GSK), Becton Dickinson, Johnson & Johnson, Abbott, Eli Lilly, and...
